# Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication

> **NCT01163435** · PHASE4 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 618 (actual)

## Conditions studied

- Helicobacter Infection

## Interventions

- **DRUG:** high dose dual therapy
- **DRUG:** sequential therapy
- **DRUG:** clarithromycin-based triple therapy
- **DRUG:** levofloxacin-based triple therapy

## Key facts

- **NCT ID:** NCT01163435
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2013-07
- **Final completion:** 2013-10
- **Target enrollment:** 618 (ACTUAL)
- **Last updated:** 2013-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01163435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01163435, "Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01163435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*